Project Grant HT94252510732
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $1,127,311.00 to the University of Wisconsin - Madison to develop CA9-targeted radiopharmaceutical agents for kidney cancer theranostics. The award period runs from September 1, 2024 to August 31, 2028. Through this grant, the university will conduct advanced biomedical research to transform healthcare for military service members and the general...
This federal Project Grant award for $465,935.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is funding research conducted by the University of Wisconsin - Madison to combine PSMA and BRD4 disruption approaches to overcome resistance in advanced prostate cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical solutions to critical...
The U.S. Department of Defense's Defense Health Agency awarded a $395,202 Project Grant to The University of Texas Southwestern Medical Center in Dallas, Texas under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "PET IMAGING OF HIF 2A IN RENAL CANCER," supports research to develop new imaging techniques for detecting and monitoring kidney cancer in military personnel and veterans. The three-year award, running from September 1, 2023 to August...
This $834,798 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports PET imaging research of HIF 2A in renal cancer at The University of Texas Southwestern Medical Center in Dallas, Texas. The research project aims to develop new diagnostic and treatment approaches for kidney cancer, which is a key focus area for this Defense Department program. The award will fund basic, translational, and clinical research...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...
This federal Project Grant award, valued at $155,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the University of Wisconsin System to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The research aims to transform healthcare for military service members and the broader public through innovative biomedical investigations. The one-year project will run from...
This federal Project Grant award of $1,251,230.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a breast cancer research project with the University of Wisconsin System. The award will fund a clinical trial focused on breakthrough breast cancer treatments, with a performance period from June 2025 to June 2029. The University of Wisconsin System, a leading public research institution, will serve as the primary awardee and perform the...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
The federal Project Grant award of $1,225,783 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a fully automated deep learning-based framework for segmentation and treatment response assessment of lesions on PSMA PET/CT in prostate cancer. This research, conducted by the University of Colorado-Denver, aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
This $785,833 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. Awarded to the University of Wisconsin System, the research aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis,...